These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21458064)
1. A cationic prodrug/therapeutic gene nanocomplex for the synergistic treatment of tumors. Lu X; Wang QQ; Xu FJ; Tang GP; Yang WT Biomaterials; 2011 Jul; 32(21):4849-56. PubMed ID: 21458064 [TBL] [Abstract][Full Text] [Related]
2. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. Wiradharma N; Tong YW; Yang YY Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093 [TBL] [Abstract][Full Text] [Related]
3. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome. Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367 [TBL] [Abstract][Full Text] [Related]
4. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Xiong XB; Ma Z; Lai R; Lavasanifar A Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492 [TBL] [Abstract][Full Text] [Related]
5. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release. Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin. Qi X; Chang Z; Song J; Gao G; Shen Z Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162 [TBL] [Abstract][Full Text] [Related]
7. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. Han L; Huang R; Li J; Liu S; Huang S; Jiang C Biomaterials; 2011 Feb; 32(4):1242-52. PubMed ID: 20971503 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Hu FQ; Liu LN; Du YZ; Yuan H Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395 [TBL] [Abstract][Full Text] [Related]
9. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. Lee ES; Na K; Bae YH J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623 [TBL] [Abstract][Full Text] [Related]
11. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167 [TBL] [Abstract][Full Text] [Related]
12. A duplex oligodeoxynucleotide-dendrimer bioconjugate as a novel delivery vehicle for doxorubicin in in vivo cancer therapy. Lee IH; Yu MK; Kim IH; Lee JH; Park TG; Jon S J Control Release; 2011 Oct; 155(1):88-95. PubMed ID: 20854858 [TBL] [Abstract][Full Text] [Related]
13. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy. Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912 [TBL] [Abstract][Full Text] [Related]
14. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059 [TBL] [Abstract][Full Text] [Related]
15. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice. Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510 [TBL] [Abstract][Full Text] [Related]
16. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455 [TBL] [Abstract][Full Text] [Related]
17. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684 [TBL] [Abstract][Full Text] [Related]
18. Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine. Jiang QY; Lai LH; Shen J; Wang QQ; Xu FJ; Tang GP Biomaterials; 2011 Oct; 32(29):7253-62. PubMed ID: 21715001 [TBL] [Abstract][Full Text] [Related]
19. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599 [TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Wong HL; Rauth AM; Bendayan R; Wu XY Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]